摘要
目的观察丹参酮ⅡA磺酸钠治疗眼底出血的临床疗效。方法随机选取入院的眼底出血患者48例55眼,用丹参酮ⅡA磺酸钠注射液治疗14d。对比分析以往采用血栓通注射液治疗的眼底出血患者50例58眼。结果丹参酮ⅡA磺酸钠治疗组有效48眼,总有效率达87.27%,其中40眼在治疗10d内开始有效,占83.33%.血栓通对照组有效40眼,总有效率为68.97%,其中25眼在治疗10d内开始有效,占62.50%.2组疗效和起效速度相比差异均无统计学意义(P<0.05)。结论丹参酮ⅡA磺酸钠是治疗眼底出血的有效方法,优于血栓通注射液。
Objective To observe the clinical curafire effect of Sodimn Tanshinone Ⅱ A Sulfonate （STS） in the treatment of subhyaloid hemorrhage. Methods Forty-eight cases（ 55 eyes） of subhyaloid hemorrhage were treated with STS for 14 days,compared with 50 patients（58 eyes） treated with Xueshuantong at formet years. Results ARer STS treatment,the total effective rate was 87.27% （48 eyes） ,and vision acuity of 40 eyes began to increase in 10 days treatment,accounting for 83. 33%. In Xueshuantong treatment group, they were 68.97% （40 eyes）, and 62.50% （ 25 eyes）, respectively. There was significant difference with curative effective and the effective rate between the two groups（P 〈0.05）.Conclusion STS is a safe and effective way to treat subhyaloid hemorrhage, better than Xueshuantong.
出处
《眼科新进展》
CAS
2008年第9期702-703,共2页
Recent Advances in Ophthalmology
关键词
眼底出血
丹参酮ⅡA磺酸钠
血栓通
subhyaloid hemorrhage
Sodimn Tanshinone Ⅱ A Sulfonate
Xueshuantong
